Research Archive — Page 6 of 133

February 18, 2026

Novel vaccine protects against C. diff disease and recurrence

New study represents a major step forward for vaccine development for C. diff, the leading cause of health care- and antibiotic-associated infection.

(iStock)
February 13, 2026

Anti-Marburg antibody from Vanderbilt Health sent to Ethiopia during outbreak

There currently are no approved treatments or vaccines to protect against the infection, which can cause internal bleeding, organ failure, and in roughly 50% of cases, death.

February 11, 2026

Vaccination cuts risk of COVID-19 respiratory failure or death by 80%

Researchers at Vanderbilt Health and around the country continue to evaluate the effectiveness of vaccines approved by the Food and Drug Administration to reduce the severity and lethality of respiratory infections caused by the ever-mutating SARS-CoV-2 virus.

February 11, 2026

Heart preservation technique increases pool of organs available for transplant

The technique, termed REUP (rapid recovery with extended ultraoxygenated preservation), avoids traditional methods that reanimate the heart within or outside the donor’s body.

February 9, 2026

AI finds patient-level statin barriers in clinical notes

A novel AI framework found documented intolerance to statins in 6.4% of all adult patients, contraindications in 0.7%, and statin deferral in 2.9%.

February 9, 2026

Vanderbilt research uncovers new clue to insulin resistance

The latest findings could lead to more targeted ways to increase insulin-stimulated glucose uptake by muscle and exercise tolerance.